CURASIGHT A/S |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.1 DKK | -8.82% |
|
-9.45% | -48.73% |
| 04-16 | Curasight A/S Announces Approval of Clinical Trial Application for Phase 2 Trial with uTRACE in Prostate Cancer Patients | CI |
| 04-12 | Curasight A/S Announces Board Changes | CI |
Chart calendar Curasight A/S
57c175dfce9f2f.jZZ9mljv2sk1wsjV6BjV9EpIMAikHMgKB02VBSYxui8.wckw1GuFsrtqpvGPkmHl2XsDASXBbYM4Kg-gMnYE5Rfm1074MN3jvG2lqw~bc735a5f5b6b2cb7c8a1443cb2650271
Upcoming events on Curasight A/S
Past events on Curasight A/S
| 21/03/2024 09:00 | Annual General Meeting |
| 21/02/2024 | Q4 2023 Earnings Release |
| 23/11/2023 06:00 | Q3 2023 Earnings Release |
| 31/08/2023 10:30 | HC Andersen Capital Life Science Seminar |
| 23/08/2023 | Q2 2023 Earnings Release |
| 31/05/2023 12:30 | Økonomisk Ugebrev Life Science Investor Conference |
| 31/05/2023 09:30 | HC Andersen Capital Presentation |
| 25/05/2023 06:32 | Q1 2023 Earnings Release |
| 30/03/2023 09:00 | Annual General Meeting |
| 27/02/2023 13:00 | Q4 2022 Earnings Call |
| 23/02/2023 06:00 | FY 2022 Earnings Release |
| 19/01/2023 05:00 | Redeye Fight Cancer Seminar |
| 08/01/2023 | SEB Nordic Seminar |
| 28/11/2022 11:00 | Q3 2022 Earnings Call |
| 23/11/2022 | Q3 2022 Earnings Release |
| 21/11/2022 12:05 | SEB Healthcare Seminar |
| 23/08/2022 | Interim 2022 Earnings Release |
| 24/05/2022 06:00 | Q1 2022 Earnings Release |
| 18/05/2022 10:00 | Kapital Partners Life Science Seminar |
| 27/04/2022 09:00 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA Million DKK | Released Forecast Spread | 0,00 | -32,1 -26,0 -23.55% | -64,0 |
|
EBIT Million DKK | Released Forecast Spread | 0,00 | -33,2 -26,0 -27.75% | -64,0 |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | -19,5 | 0,00 0,00 - | 0,00 |
|
Net income Million DKK | Released Forecast Spread | -18,3 | 0,00 0,00 - | 0,00 |
|
EPS | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
| Announcement Date | 23/02/23 | 22/02/24 | - |
| Today 21:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 11:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 11:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 12:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Curasight A/S
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- CURAS Stock
- Calendar Curasight A/S
